Neurological aspects of hyperinsulinism-hyperammonaemia syndrome

Nadia Bahi-Buisson, Emmanuel Roze, Carlo Dionisi, Fabienne Escande, Vassili Valayannopoulos, François Feillet, Claudine Heinrichs

Research output: Contribution to journalArticle

Abstract

Hyperinsulinism-hyperammonaemia syndrome (HHS) is a rare cause of congenital hyperinsulinism, due to missense mutations in the GLUD1 gene, resulting in glutamate dehydrogenase (GDH) overactivity. The aim of this study was to document the spectrum of neurological disturbances associated with HHS and to identify possible phenotype-genotype correlations. We retrospectively analyzed the neurological outcomes of 22 consecutive patients (12 males, 10 females) aged from 18 months to 40 years and diagnosed with HHS. We analyzed demographic and clinical features and neuroradiological, biochemical, and genetic findings. Fourteen patients had childhood-onset epilepsy. Learning disability* was found in 17 patients. Two patients had pyramidal involvement and one had generalized dystonia. Seizures were observed in 11 of 19 patients with documented GLUD1 mutations, and nine of these 11 patients had a mutation in the guanosine triphosphate (GTP) binding site. Our data demonstrate that neurological disorders in HHS are more frequent than previously thought and might suggest that mutations in the GTP binding site of GDH could be associated with more frequent epilepsy.

Original languageEnglish
Pages (from-to)945-949
Number of pages5
JournalDevelopmental Medicine and Child Neurology
Volume50
Issue number12
DOIs
Publication statusPublished - 2008

Fingerprint

Glutamate Dehydrogenase
Guanosine Triphosphate
Mutation
Epilepsy
Congenital Hyperinsulinism
Binding Sites
Dystonia
Learning Disorders
Genetic Association Studies
Missense Mutation
Nervous System Diseases
Hyperinsulinemic hypoglycemia, familial, 6
Molecular Biology
Seizures
Demography
Genes

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience

Cite this

Bahi-Buisson, N., Roze, E., Dionisi, C., Escande, F., Valayannopoulos, V., Feillet, F., & Heinrichs, C. (2008). Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Developmental Medicine and Child Neurology, 50(12), 945-949. https://doi.org/10.1111/j.1469-8749.2008.03114.x

Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. / Bahi-Buisson, Nadia; Roze, Emmanuel; Dionisi, Carlo; Escande, Fabienne; Valayannopoulos, Vassili; Feillet, François; Heinrichs, Claudine.

In: Developmental Medicine and Child Neurology, Vol. 50, No. 12, 2008, p. 945-949.

Research output: Contribution to journalArticle

Bahi-Buisson, N, Roze, E, Dionisi, C, Escande, F, Valayannopoulos, V, Feillet, F & Heinrichs, C 2008, 'Neurological aspects of hyperinsulinism-hyperammonaemia syndrome', Developmental Medicine and Child Neurology, vol. 50, no. 12, pp. 945-949. https://doi.org/10.1111/j.1469-8749.2008.03114.x
Bahi-Buisson, Nadia ; Roze, Emmanuel ; Dionisi, Carlo ; Escande, Fabienne ; Valayannopoulos, Vassili ; Feillet, François ; Heinrichs, Claudine. / Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. In: Developmental Medicine and Child Neurology. 2008 ; Vol. 50, No. 12. pp. 945-949.
@article{a62c0ea43b1942cbb61bf78d11b966c8,
title = "Neurological aspects of hyperinsulinism-hyperammonaemia syndrome",
abstract = "Hyperinsulinism-hyperammonaemia syndrome (HHS) is a rare cause of congenital hyperinsulinism, due to missense mutations in the GLUD1 gene, resulting in glutamate dehydrogenase (GDH) overactivity. The aim of this study was to document the spectrum of neurological disturbances associated with HHS and to identify possible phenotype-genotype correlations. We retrospectively analyzed the neurological outcomes of 22 consecutive patients (12 males, 10 females) aged from 18 months to 40 years and diagnosed with HHS. We analyzed demographic and clinical features and neuroradiological, biochemical, and genetic findings. Fourteen patients had childhood-onset epilepsy. Learning disability* was found in 17 patients. Two patients had pyramidal involvement and one had generalized dystonia. Seizures were observed in 11 of 19 patients with documented GLUD1 mutations, and nine of these 11 patients had a mutation in the guanosine triphosphate (GTP) binding site. Our data demonstrate that neurological disorders in HHS are more frequent than previously thought and might suggest that mutations in the GTP binding site of GDH could be associated with more frequent epilepsy.",
author = "Nadia Bahi-Buisson and Emmanuel Roze and Carlo Dionisi and Fabienne Escande and Vassili Valayannopoulos and Fran{\cc}ois Feillet and Claudine Heinrichs",
year = "2008",
doi = "10.1111/j.1469-8749.2008.03114.x",
language = "English",
volume = "50",
pages = "945--949",
journal = "Developmental Medicine and Child Neurology",
issn = "0012-1622",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Neurological aspects of hyperinsulinism-hyperammonaemia syndrome

AU - Bahi-Buisson, Nadia

AU - Roze, Emmanuel

AU - Dionisi, Carlo

AU - Escande, Fabienne

AU - Valayannopoulos, Vassili

AU - Feillet, François

AU - Heinrichs, Claudine

PY - 2008

Y1 - 2008

N2 - Hyperinsulinism-hyperammonaemia syndrome (HHS) is a rare cause of congenital hyperinsulinism, due to missense mutations in the GLUD1 gene, resulting in glutamate dehydrogenase (GDH) overactivity. The aim of this study was to document the spectrum of neurological disturbances associated with HHS and to identify possible phenotype-genotype correlations. We retrospectively analyzed the neurological outcomes of 22 consecutive patients (12 males, 10 females) aged from 18 months to 40 years and diagnosed with HHS. We analyzed demographic and clinical features and neuroradiological, biochemical, and genetic findings. Fourteen patients had childhood-onset epilepsy. Learning disability* was found in 17 patients. Two patients had pyramidal involvement and one had generalized dystonia. Seizures were observed in 11 of 19 patients with documented GLUD1 mutations, and nine of these 11 patients had a mutation in the guanosine triphosphate (GTP) binding site. Our data demonstrate that neurological disorders in HHS are more frequent than previously thought and might suggest that mutations in the GTP binding site of GDH could be associated with more frequent epilepsy.

AB - Hyperinsulinism-hyperammonaemia syndrome (HHS) is a rare cause of congenital hyperinsulinism, due to missense mutations in the GLUD1 gene, resulting in glutamate dehydrogenase (GDH) overactivity. The aim of this study was to document the spectrum of neurological disturbances associated with HHS and to identify possible phenotype-genotype correlations. We retrospectively analyzed the neurological outcomes of 22 consecutive patients (12 males, 10 females) aged from 18 months to 40 years and diagnosed with HHS. We analyzed demographic and clinical features and neuroradiological, biochemical, and genetic findings. Fourteen patients had childhood-onset epilepsy. Learning disability* was found in 17 patients. Two patients had pyramidal involvement and one had generalized dystonia. Seizures were observed in 11 of 19 patients with documented GLUD1 mutations, and nine of these 11 patients had a mutation in the guanosine triphosphate (GTP) binding site. Our data demonstrate that neurological disorders in HHS are more frequent than previously thought and might suggest that mutations in the GTP binding site of GDH could be associated with more frequent epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=56849124017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56849124017&partnerID=8YFLogxK

U2 - 10.1111/j.1469-8749.2008.03114.x

DO - 10.1111/j.1469-8749.2008.03114.x

M3 - Article

C2 - 19046187

AN - SCOPUS:56849124017

VL - 50

SP - 945

EP - 949

JO - Developmental Medicine and Child Neurology

JF - Developmental Medicine and Child Neurology

SN - 0012-1622

IS - 12

ER -